2023 Q1 Form 10-K Financial Statement

#000106299323007681 Filed on March 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $75.00K $300.0K
YoY Change -100.0% 0.0% -62.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $129.6K $103.4K $630.8K
YoY Change -52.97% 17.63% 47.06%
% of Gross Profit
Research & Development $18.43K -$3.150K $160.00
YoY Change 1475.21% 12.5% -98.37%
% of Gross Profit
Depreciation & Amortization $331.00 $330.00 $1.553K
YoY Change -40.89% -46.77% -45.51%
% of Gross Profit
Operating Expenses $213.1K $100.6K $746.3K
YoY Change -23.12% 17.33% 68.97%
Operating Profit -$213.1K -$446.3K
YoY Change -21.86% -263.46%
Interest Expense -$147.4K $68.99K -$782.1K
YoY Change -38.33% -348.43% -7.89%
% of Operating Profit
Other Income/Expense, Net -$146.7K -$16.05K -$797.5K
YoY Change -146798.0% -2033.73% -8759.41%
Pretax Income -$359.8K $20.00K -$1.244M
YoY Change -29.68% -136.86% 119.44%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$359.8K $19.06K -$1.245M
YoY Change -29.68% -132.16% 117.69%
Net Earnings / Revenue 25.41% -414.91%
Basic Earnings Per Share -$0.01 -$0.02
Diluted Earnings Per Share -$0.01 $0.00 -$0.02
COMMON SHARES
Basic Shares Outstanding 60.86M shares 60.86M shares
Diluted Shares Outstanding 60.86M shares 60.86M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.055M $1.421M $1.421M
YoY Change -4.17% 22.89% 22.89%
Cash & Equivalents $464.2K $682.7K $682.7K
Short-Term Investments $591.2K $738.6K $738.6K
Other Short-Term Assets $42.86K $20.11K $20.11K
YoY Change 1291.56% 9.35% 9.35%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.098M $1.441M $1.441M
YoY Change -0.55% 22.67% 22.67%
LONG-TERM ASSETS
Property, Plant & Equipment $290.6K $280.9K $280.9K
YoY Change 3.08% -0.55% -0.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $326.2K $280.9K $280.9K
YoY Change -79.13% -84.42% -84.42%
TOTAL ASSETS
Total Short-Term Assets $1.098M $1.441M $1.441M
Total Long-Term Assets $326.2K $280.9K $280.9K
Total Assets $1.424M $1.722M $1.722M
YoY Change -46.61% -42.17% -42.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $64.36K $27.60K $27.60K
YoY Change 144.62% 140.0% 140.0%
Accrued Expenses $141.7K $146.7K $146.7K
YoY Change -42.61% -12.0% -40.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.264M $1.221M $1.221M
YoY Change -12.56% -12.95% -12.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.2K $81.25K $81.25K
YoY Change 54.12% 25.0% 25.0%
Total Long-Term Liabilities $100.2K $81.25K $81.25K
YoY Change 54.12% 25.0% 25.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.264M $1.221M $1.221M
Total Long-Term Liabilities $100.2K $81.25K $81.25K
Total Liabilities $1.364M $1.302M $1.472M
YoY Change -19.01% -11.26% -10.32%
SHAREHOLDERS EQUITY
Retained Earnings -$6.711M -$6.351M
YoY Change 24.37%
Common Stock $60.86K $60.86K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 11.70K shares 11.70K shares
Shareholders Equity -$109.6K $250.2K $250.2K
YoY Change
Total Liabilities & Shareholders Equity $1.424M $1.722M $1.722M
YoY Change -46.61% -42.17% -42.17%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$359.8K $19.06K -$1.245M
YoY Change -29.68% -132.16% 117.69%
Depreciation, Depletion And Amortization $331.00 $330.00 $1.553K
YoY Change -40.89% -46.77% -45.51%
Cash From Operating Activities -$208.5K -$124.3K -$402.1K
YoY Change 276.89% 110.89% 55.98%
INVESTING ACTIVITIES
Capital Expenditures $10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$10.00K $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 -33.77K -$71.77K
YoY Change 575.4% 674.2%
NET CHANGE
Cash From Operating Activities -$208.5K -124.3K -$402.1K
Cash From Investing Activities -$10.00K 0.000 $0.00
Cash From Financing Activities $0.00 -33.77K -$71.77K
Net Change In Cash -$218.5K -158.1K -$473.9K
YoY Change 294.96% 147.2% -153.7%
FREE CASH FLOW
Cash From Operating Activities -$208.5K -$124.3K -$402.1K
Capital Expenditures $10.00K
Free Cash Flow -$218.5K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
80177 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
66768 usd
CY2022 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 usd
CY2021 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
634 usd
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
11700 shares
CY2022 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
0 usd
CY2021 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
500000 usd
CY2022 us-gaap Revenues
Revenues
300000 usd
CY2021 us-gaap Revenues
Revenues
800000 usd
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
500000 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1156622 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
274155 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
682718 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1156622 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
400000 shares
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
710000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.1
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1640000 shares
CY2022 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 usd
CY2021 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
92685 usd
CY2022 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
-20000 usd
CY2021 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
-20000 usd
CY2022 thmg Shares Issued For Settlement Of Option Exercise With Accrued Interest And Wages
SharesIssuedForSettlementOfOptionExerciseWithAccruedInterestAndWages
0 usd
CY2021 thmg Shares Issued For Settlement Of Option Exercise With Accrued Interest And Wages
SharesIssuedForSettlementOfOptionExerciseWithAccruedInterestAndWages
35466 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-left: 18pt; text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Accounting Estimates</span></span></span></p> <p style="margin-left: 18pt; text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions include the carrying value of properties and mineral interests, environmental remediation liabilities, deferred tax assets, and stock-based compensation. Management's estimates and assumptions are based on historical experience and other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates.</span></span></p> </div>
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
710000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.1
CY2021Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
35534 usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
355352 shares
CY2021Q3 thmg Additional Common Shares To Settle Advanced Funds Accrued Wages And Accrued Interest
AdditionalCommonSharesToSettleAdvancedFundsAccruedWagesAndAccruedInterest
354648 shares
CY2021Q3 thmg Value Of Additional Common Shares To Settle Advanced Funds Accrued Wages And Accrued Interest
ValueOfAdditionalCommonSharesToSettleAdvancedFundsAccruedWagesAndAccruedInterest
35466 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000 usd
CY2021Q3 thmg Additional Common Shares To Settle Advanced Funds Accrued Wages And Accrued Interest
AdditionalCommonSharesToSettleAdvancedFundsAccruedWagesAndAccruedInterest
354648 shares
CY2021Q3 thmg Value Of Additional Common Shares To Settle Advanced Funds Accrued Wages And Accrued Interest
ValueOfAdditionalCommonSharesToSettleAdvancedFundsAccruedWagesAndAccruedInterest
35466 usd
CY2021Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
35534 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
0.267 pure
CY2022Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
0 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
3600 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
1.186 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.169 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1.453 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
11988 usd
CY2022 dei Auditor Name
AuditorName
Assure CPA LLC
CY2022Q4 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
738612 usd
CY2021Q4 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
1520684 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
11700 shares
CY2022 thmg Reclamation Expense
ReclamationExpense
16250 usd
CY2021 thmg Reclamation Expense
ReclamationExpense
0 usd
CY2022 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 usd
CY2021 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
92685 usd
CY2022 thmg Proceeds From Royalty Interests In Mining Properties
ProceedsFromRoyaltyInterestsInMiningProperties
0 usd
CY2021 thmg Proceeds From Royalty Interests In Mining Properties
ProceedsFromRoyaltyInterestsInMiningProperties
500000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
35534 usd
CY2022 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
5000 usd
CY2021 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
5000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1820000 shares
CY2021Q4 us-gaap Oil And Gas Reclamation Liability Noncurrent
OilAndGasReclamationLiabilityNoncurrent
65000 usd
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3355000 shares
CY2021Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
1041500 usd
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
710000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
355352 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5705000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3355000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4775000 shares
CY2022 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.088 pure

Files In Submission

Name View Source Status
0001062993-23-007681-index-headers.html Edgar Link pending
0001062993-23-007681-index.html Edgar Link pending
0001062993-23-007681.txt Edgar Link pending
0001062993-23-007681-xbrl.zip Edgar Link pending
exhibit21-1.htm Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
form10kxz001.jpg Edgar Link pending
form10kxz002.jpg Edgar Link pending
form10kxz003.jpg Edgar Link pending
form10kxz004.jpg Edgar Link pending
form10kxz005.jpg Edgar Link pending
form10kxz006.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
form10k_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thmg-20221231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
thmg-20221231_cal.xml Edgar Link unprocessable
thmg-20221231_def.xml Edgar Link unprocessable
thmg-20221231_lab.xml Edgar Link unprocessable
thmg-20221231_pre.xml Edgar Link unprocessable